Ocean Biomedical, Inc. 8-K Report: Key Financial Insights & Stock Details

$OCEA
Form 8-K
Filed on: 2025-02-21
Source
Ocean Biomedical, Inc. 8-K Report: Key Financial Insights & Stock Details

Based on the provided XML section of the financial report for Ocean Biomedical, Inc., here are the key pieces of information extracted:

  1. Company Information:
  • Name: Ocean Biomedical, Inc.
  • CIK: 0001869974
  • Address: 55 Claverick St., Room 325, Providence, RI 02903
  • Phone: (401) 444-7375
  • Ticker Symbols:
    • Common Stock: OCEA (NASDAQ)
    • Warrants: OCEAW (NASDAQ)
  1. Report Context:
  • Filing Date: February 21, 2025
  • Period Ending: February 21, 2025
  1. Stock Information:
  • Common Stock:
    • Par Value: $0.0001
  • Warrants:
    • Each warrant is exercisable for one share of common stock.
    • Exercise Price: $11.50
  1. Units of Measure:
  • Currency: USD
  • Shares: Denoted in shares.
  1. Document Type:
  • Form 8-K filed on February 21, 2025.

Insights:

  • Financial Instruments: The report references both common stock and warrants, indicating potential capital raising or investment strategies.
  • Warrant Exercise Price: The exercise price of $11.50 per share for the warrants provides insight into the company's valuation expectations and market performance.
  • Low Par Value: The low par value of $0.0001 for common stock may suggest a startup or growth-stage company structure.
  • Regulatory Compliance: The filing indicates adherence to SEC regulations, which is crucial for maintaining investor trust and market credibility.

This information is essential for investors evaluating the company's financial health and strategic direction.